Genprex, Inc. Files 8-K: Other Events & Financials
Ticker: GNPX · Form: 8-K · Filed: Oct 21, 2025 · CIK: 1595248
Sentiment: neutral
Topics: 8-k, regulatory-filing, pharmaceuticals
Related Tickers: GNPX
TL;DR
Genprex filed an 8-K on 10/21/25 for other events and financials. Keep an eye on this one.
AI Summary
Genprex, Inc. filed an 8-K on October 21, 2025, reporting other events and financial statements. The company, incorporated in Delaware with its principal executive offices in Austin, TX, operates in the Pharmaceutical Preparations industry. This filing does not contain specific financial figures or details about the 'other events' beyond its classification.
Why It Matters
This 8-K filing indicates Genprex, Inc. is providing updates on its operations and financial status, which is crucial for investors to monitor the company's progress and potential risks.
Risk Assessment
Risk Level: low — The filing is a standard 8-K for 'Other Events' and 'Financial Statements and Exhibits' without specific material disclosures that would immediately indicate high risk.
Key Players & Entities
- Genprex, Inc. (company) — Registrant
- October 21, 2025 (date) — Date of report
- Austin, TX (location) — Principal executive offices location
- Delaware (location) — State of incorporation
- 2834 (industry_code) — Standard Industrial Classification for Pharmaceutical Preparations
FAQ
What specific 'Other Events' are being reported by Genprex, Inc. in this 8-K filing?
The filing indicates 'Other Events' as an item information, but the specific details of these events are not provided in the excerpt.
When was Genprex, Inc. incorporated, and where are its principal executive offices located?
Genprex, Inc. was incorporated in Delaware and its principal executive offices are located at 3300 Bee Cave Road, #650-227, Austin, TX 78746.
What is Genprex, Inc.'s Standard Industrial Classification (SIC) code, and what industry does it represent?
Genprex, Inc.'s SIC code is 2834, which corresponds to Pharmaceutical Preparations.
What is the filing date and the earliest event date reported in this 8-K?
The filing date and the date of the earliest event reported are both October 21, 2025.
What is the Commission File Number and IRS Employer Identification Number for Genprex, Inc.?
The Commission File Number for Genprex, Inc. is 001-38244, and its IRS Employer Identification Number is 90-0772347.
Filing Stats: 468 words · 2 min read · ~2 pages · Grade level 10.6 · Accepted 2025-10-21 07:10:41
Key Financial Figures
- $0.001 — h registered Common Stock , par value $0.001 per share GNPX The Nasdaq Capital Ma
Filing Documents
- gnpx20251021c_8k.htm (8-K) — 26KB
- 0001437749-25-031382.txt ( ) — 156KB
- gnpx-20251021.xsd (EX-101.SCH) — 3KB
- gnpx-20251021_def.xml (EX-101.DEF) — 12KB
- gnpx-20251021_lab.xml (EX-101.LAB) — 15KB
- gnpx-20251021_pre.xml (EX-101.PRE) — 12KB
- gnpx20251021c_8k_htm.xml (XML) — 3KB
01 Other Events
Item 8.01 Other Events. As of 12:01 a.m. on October 21, 2025, Genprex, Inc., a Delaware corporation (the "Company"), effected the previously disclosed one-for-fifty (1:50) reverse stock split (the "Reverse Stock Split") of the Company's issued and outstanding shares of common stock, par value $0.001 per share (the "Common Stock"). After giving effect to the Reverse Stock Split, as of October 21, 2025, and prior to any rounding applied to any fractional shares resulting from the Reverse Stock Split, the Company has 1,004,326 shares of Common Stock outstanding.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits. Exhibit Number Description 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. GENPREX, INC. Date: October 21, 2025 By: /s/ Ryan Confer Ryan Confer Chief Executive Officer and Chief Financial Officer (Principal Executive Officer and Principal Financial and Accounting Officer)